GeoVax Labs Inc. Common Stock (GOVX)
Stock · NASDAQ · Health Care
$0.2319as of 10/16/2026
Price chart
Active signals
GOVX Signal Track Record
How signals performed across all stocks →What GOVX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 25 | -3.7% | 36% | October 5, 2026 |
| Bollinger Band Breakdown | 20 | -7.8% | 35% | September 3, 2026 |
| Bollinger Band Breakout | 16 | -13.5% | 38% | May 20, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -12.1% | 0% | December 27, 2024 |
| Any 20-session window (baseline) | -12.9% | 26% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About GOVX
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phas…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 19
- Website
- www.geovax.com/
Fundamentals
- 1-day range
- $0.226$0.2598
- Market cap
- $5.31M
- P/E (trailing)
- —
- P/E (forward)
- -0.30
- EPS (trailing)
- $-13.92
- Dividend yield
- —
- Beta
- 3.89
- Avg. volume
- 776.2K
- Dividend pay date
- September 25, 2020
How GeoVax Labs Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Apr 15, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
GeoVax Labs Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GOVXGeoVax Labs Inc. Common Stock$0.238▼ 7.75%Market cap $5.31MP/E —$0.24$15.75
- BGMSBio Green Med Solution Inc. Common Stock$0.91▲ 9.64%Market cap $5.35MP/E —$0.5664$6.11
- CURXCuranex Pharmaceuticals Inc Common Stock$4.62▼ 4.35%Market cap $5.53MP/E —$3.58$16.94
- ERNAErnexa Therapeutics Inc. Common Stock$2.09▼ 3.69%Market cap $5.09MP/E —$2.01$71.5
- NCNANuCana plc American Depositary Share$0.99▼ 2.94%Market cap $5.66MP/E 0.01$0.9484$6.1
- SILOSilo Pharma Inc. Common Stock$1.18▼ 1.67%Market cap $5.85MP/E —$1.3$10.44
- PPCBPropanc Biopharma Inc. Common Stock$0.342▲ 0.15%Market cap $4.76MP/E —$0.365$47.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GOVX GeoVax Labs Inc. Common Stock | $5.31M | — | $0.238 | ▼ 7.75% | $0.24$15.75 |
| BGMS Bio Green Med Solution Inc. Common Stock | $5.35M | — | $0.91 | ▲ 9.64% | $0.5664$6.11 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $5.53M | — | $4.62 | ▼ 4.35% | $3.58$16.94 |
| ERNA Ernexa Therapeutics Inc. Common Stock | $5.09M | — | $2.09 | ▼ 3.69% | $2.01$71.5 |
| NCNA NuCana plc American Depositary Share | $5.66M | 0.01 | $0.99 | ▼ 2.94% | $0.9484$6.1 |
| SILO Silo Pharma Inc. Common Stock | $5.85M | — | $1.18 | ▼ 1.67% | $1.3$10.44 |
| PPCB Propanc Biopharma Inc. Common Stock | $4.76M | — | $0.342 | ▲ 0.15% | $0.365$47.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Curious about the stocks that are showing activity after the closing bell on Tuesday?ChartMill · 10/6/2026
- GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026Yahoo · 10/6/2026
- What's going on in today's pre-market sessionChartMill · 10/6/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 10/6/2026
- Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving PremarketBenzinga · 10/6/2026
- These stocks are moving in today's after hours sessionChartMill · 10/5/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 10/5/2026
- GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United StatesYahoo · 9/29/2026
Insider Activity
Insider Actions →- Morgan Jayne · June 17, 2026 · Grant6.0K
- Lemerond Nicole · June 17, 2026 · Grant6.0K
- McKee Kelly T. Jr. · June 17, 2026 · Grant17.6K
- Sharkey John W. · June 17, 2026 · Grant17.6K
- Kollintzas Dean G · June 17, 2026 · Grant6.0K
- Reynolds Mark · June 17, 2026 · Grant17.6K
- SPENCER JOHN N JR · June 17, 2026 · Grant6.0K
- NEWMAN MARK J · June 17, 2026 · Grant17.6K
- DODD DAVID A · June 17, 2026 · Grant29.3K
- CHASE RANDAL D · June 17, 2026 · Grant6.0K
- MCNALLY ROBERT T · June 17, 2026 · Grant6.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 328.3K
- Total value held
- $438.6K
- Institutional holders
- 15
- Unknown269.3K
- Unknown36.1K
- Unknown10.5K
- Unknown4.2K
- Unknown3.5K
- Unknown3.2K
- Unknown1.1K
- Unknown384
- Unknown31
- Unknown6
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GeoVax Notes Sustained Clade Ib Mpox Transmission in US
GeoVax Labs reported that Clade Ib mpox transmission in the United States is likely to be sustained. This development is relevant as the company focuses on mpox-related solutions. The stock currently trades near its 52-week low, reflecting broader market conditions.
GeoVax Notes Sustained Clade Ib Mpox Transmission in US. GeoVax Labs reported that Clade Ib mpox transmission in the United States is likely to be sustained. This development is relevant as the company focuses on mpox-related solutions. The stock currently trades near its 52-week low, reflecting broader market conditions.